News Releases and Announcements

Enter a Year (YYYY)
ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines
October 30, 2023
JP and USP Prepare a Pilot Program to Promote Harmonization of Pharmacopoeial Standards of Drug Substances and Drug Products
October 25, 2023
Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member, facilitating reach and enhancing impact of pharmacopoeial standards harmonisation
October 5, 2023
USP Welcomes Executive Delegation from the South African Health Products Regulatory Authority
August 31, 2023
Expert Committee Proposes Chapter for Endotoxin Testing Using Non-Animal Derived Reagents
August 22, 2023
Donated laboratory equipment to help Ghana protect patients from poor-quality medicines
July 24, 2023
U.S. Pharmacopeia statement on supply chain impact of tornado damage to Pfizer Inc. Rocky Mount facility
July 21, 2023
Pharmaceutical Continuous Manufacturing: Knowledge Center Debuts to Expand Information Access, Facilitate Innovation, and Address Barriers to PCM Adoption
July 11, 2023
USP and Africa CDC Launch MOU to Advance Regional Manufacturing and Strengthen Regulatory and Laboratory Systems in Africa
June 29, 2023
Nigeria Pharmaceutical Company First to Receive WHO Prequalification in West Africa
June 6, 2023
Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer
June 5, 2023
USP and FDA Lead Effort to Bolster Resilience of Global Medicines Supply Chain During APEC United States Host Year
April 25, 2023
U.S. Pharmacopeia Issues Statement on the Decision to Suspend FDA Approval of Mifepristone in the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration Case
April 10, 2023
COVID-19 Public Health Emergency Ends in the U.S., but Need to Ensure Access to Quality Assured Vaccines Remains
April 4, 2023
USP Names Fouad Atouf Senior Vice President, Biologics
March 15, 2023
USP Names Paula Henderson Chief People Officer
February 28, 2023
ATCC and USP Enter Strategic Collaboration to Support Global Quality Production of Biologics
February 23, 2023
U.S. Pharmacopeia Issues Statement on Inclusion of Provisions to Build Supply Chain Resilience and Improve Upstream Visibility in Fiscal Year 2023 Government Funding Legislation
January 3, 2023
USP Launches R&D Analytical Solutions To Advance Continuous Manufacturing Technologies
December 12, 2022
USP Expands Support for Controlling Impurities in Medicines
October 19, 2022
U.S. Pharmacopeia Celebrates World Standards Week
October 7, 2022
U.S. Pharmacopeia Awarded FDA Funding to Create a Multi-Attribute Method (MAM) Knowledge Base
September 29, 2022
Proposed Cannabis Monograph Open for Public Comment in USP Herbal Medicines Compendium
September 26, 2022
USP removed all current members of the Microbiology Expert Committee 
September 21, 2022
U.S. Pharmacopeia expands efforts to promote medicine quality in Asia Pacific
September 7, 2022